Item List

Invitae and Simons Searchlight Partner to Accelerate Research through Data Sharing

Invitae (NYSE: NVTA), a leading medical genetics company, today announced a collaboration with Simons Searchlight, an international research program with a goal of accelerating research and improving lives for people with rare genetic neurodevelopmental disorders. This partnership will connect two sets of data – the longitudinal clinical data extracted from medical records through Invitae's Ciitizen, a patient-consented, digital natural history data platform and patient reported outcomes and biospecimens collected by Simons Searchlight. The partnership breaks down data silos and provides a rich and deep dataset that will help accelerate research for rare neurodevelopmental diseases.

Recent Posts

Portfolio Company


Physician Burnout Has Reached Distressing Levels, New Research Finds ...

New York Times

General News


Private Equity Sees the Billions in Eye Care as Firms Target High-Profit Procedu ...

Kaiser Family Foundation

General News


CIOs look forward to Big Tech, digital health collaborations ...

Beckers Hospital Review

surf break copy_edited_edited.jpg